NCT01742429View on ClinicalTrials.gov

Levofloxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Cure Rate of Helicobacter Pylori Infection
Interventions
DRUG

Proton pump inhibitor

DRUG

Bismuth subsalicylate

DRUG

Metronidazole

antibiotic

DRUG

Tetracycline

antibiotic

DRUG

Amoxicillin

antibiotic

DRUG

Levofloxacin

antibiotic

Trial Locations (1)

200127

Renji Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT01742429 - Levofloxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection | Biotech Hunter | Biotech Hunter